Samsung Pharmaceutical Co., Ltd. logo

Samsung Pharmaceutical Co., Ltd. (001360)

Market Closed
12 Dec, 06:30
KRX SM KRX SM
1,866. 00
-54
-2.81%
131.67B Market Cap
- P/E Ratio
0% Div Yield
6,192,186 Volume
- Eps
1,920
Previous Close
Day Range
1,832 1,974
Year Range
1,338 2,290
Want to track 001360 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 57 days

Summary

001360 closed Friday lower at ₩1,866, a decrease of 2.81% from Thursday's close, completing a monthly increase of 38.94% or ₩523. Over the past 12 months, 001360 stock gained 21.96%.
001360 is not paying dividends to its shareholders.
The last earnings report, released on Nov 12, 2025, missed the consensus estimates by -320.55%. On average, the company has surpassed earnings expectations by 250.21%, based on the last three reports. The next scheduled earnings report is due on Feb 09, 2026.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on KRX SM (KRW).

001360 Chart

Similar

H.S. Industries Co. Ltd.
3,775
+0.67%
Motrex Co. Ltd.
8,650
+1.65%
JTC Inc.
3,850
-0.52%
Chinyang Holdings Corp.
3,345
+1.52%
Pang Rim Co., Ltd.
5,890
0%

Samsung Pharmaceutical Co., Ltd. (001360) FAQ

What is the stock price today?

The current price is ₩1,866.00.

On which exchange is it traded?

Samsung Pharmaceutical Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 001360.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 131.67B.

When is the next earnings date?

The next earnings report will release on Feb 09, 2026.

Has Samsung Pharmaceutical Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Samsung Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Sung Tag Jung CEO
KRX SM Exchange
KR7001360007 ISIN
KR Country
- Employees
- Last Dividend
2 May 2018 Last Split
- IPO Date

Overview

SAMSUNG PHARM. Co., LTD. is a prominent pharmaceutical company based in Hwaseong-si, South Korea. Founded in 1929, the company specializes in the manufacture and sale of an extensive range of pharmaceutical products. Its offerings encompass a wide array of prescription medicines tailored to address various health concerns, including serious conditions like cancer. SAMSUNG PHARM. Co., LTD. dedicates itself to improving public health through its innovative drugs and treatments, leveraging decades of expertise and a commitment to quality and effectiveness.

Products and Services

The company’s product portfolio includes an impressive selection of pharmaceutical products, catering to a broad spectrum of health needs:

  • Anticancer Immunotherapy: SAMSUNG PHARM provides advanced treatments designed to leverage the body's immune system in the fight against cancer.
  • Antipyretic Analgesic and Antiinflammatory: They offer medicines to relieve fever, pain, and inflammation, crucial for managing symptoms of various conditions.
  • Antiobesity: A range of products aimed at helping patients manage and reduce obesity, promoting healthier weight and lifestyle.
  • Hypotensive: Medications designed to lower blood pressure, providing vital treatment for patients with hypertension.
  • Antiarteriosclerotic: Drugs to combat arteriosclerosis, a condition characterized by the thickening, hardening, and loss of elasticity in arterial walls.
  • Digestive Organs Medications: Products targeting the improvement of digestive health, including treatments for various digestive system disorders.
  • Antophlegms and Enzymes: Offerings include medications to relieve phlegm and enzyme treatments to aid in various bodily functions.
  • Osteoporosis Treatments: Treatments aimed at strengthening bone, preventing bone loss, and managing osteoporosis.
  • Transfusion Agents: Critical in managing conditions requiring blood transfusions, providing support for both treatment and recovery processes.
  • Skeletal Muscle Relaxants and Anti-spastic: Medicines designed to relieve muscle spasms and ease muscle tension, promoting relaxation and recovery.
  • Mixed Vitamins, Antibiotics, and Others: A wide range of essential vitamins and antibiotic treatments for general health and specific infections.
  • Medicines for Digestive System and Liver Disorders: Focused treatments for improving liver function and addressing various aspects of digestive health.
  • Medicines for Circulation System: Products aimed at supporting and improving the function of the circulatory system.
  • Cold Medicines: Comprehensive solutions for the treatment of cold symptoms, providing relief and recovery support.
  • Nutritional Supplements and Health Tonics: Products designed to supplement the diet and promote overall well-being through carefully formulated tonics.
  • Quasi-medicines, Vitamins and Energy Drinks, and Functional Foods: An array of products that includes quasi-medicinal products, vitamin supplements, energy-boosting drinks, and foods with specific health benefits.

Contact Information

Address: 10, Yakgongdan 4-gil, Hwaseong-si, South Korea, 445-746
Phone: 82 3 1353 6681